Tuesday, 25 Jan 2022 | Funding Deadline
Muscular Dystrophy UK invests in high-quality research to further our understanding of conditions, develop effective treatments, help people to live well and inform better care. As potential treatments emerge, Muscular Dystrophy UK are committed to increasing access to clinical trials and supporting research to improve trial design. Applications are invited to help increase understanding of the underlying causes of disease, develop potential treatments and improve the quality of life of people living with neuromuscular conditions.
Deadline for proposals: 25 January 2022
Find out more here